Medical News

RSS

TPP, University of Dundee sign collaboration agreement for drug development fund

TPP Global Development Ltd announced a collaboration agreement with the University of Dundee to establish a drug development fund.

18 Oct 2011

Gender differences in sexuality should not be taken at face value

In the racy television hit show, Sex and the City, Carrie, one of the main characters tells her best girlfriends that "Men who are too good looking are never good in bed because they never had to be."

18 Oct 2011

Facing national deficit while preserving foreign assistance

Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."

18 Oct 2011

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.

18 Oct 2011

Circadian disruption and sleep restriction increase risk of MS in teens

Researchers from Sweden have uncovered an association between shift work and increased risk of multiple sclerosis. Those who engage in off-hour employment before the age of 20 may be at risk for MS due to a disruption in their circadian rhythm and sleep pattern. Findings of this novel study appear today in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society.

18 Oct 2011

NIH awards Einstein College of Medicine $5.7M for children's IDD Research Center

The Eunice Kennedy Shriver National Institute for Child Health and Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University $5.7 million to fund the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC).

18 Oct 2011

U.S. NGOs call for Obama administration to explain delays in U.S. food aid to North Korea

"As South Korean President Lee Myung-bak continued his state visit to the United States on Friday, a group of nongovernmental organizations (NGOs) wants the Obama administration to explain what they call unconscionable delays in deciding whether to resume U.S. food assistance to North Korea," Reuters reports.

18 Oct 2011

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

18 Oct 2011

Natroba effective against head lice and nits

ParaPRO, LLC, announced that researchers have presented data showing the effectiveness of Natroba (spinosad) Topical Suspension, 0.9% against head lice and nits following one treatment without nit combing. Those data about the pediculicide, derived from a naturally-occurring soil bacterium, were presented in a poster session on Saturday, Oct. 15, 2011 at the American Academy of Pediatrics National Conference and Exhibition in Boston.

18 Oct 2011

Obese asthmatic children more likely to have respiratory complications during or after surgery

A study presented at ANESTHESIOLOGY 2011 found that obese asthmatic children were nearly two times as likely to have at least one respiratory complication during or after surgery compared to their lean peers.

18 Oct 2011

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.

18 Oct 2011

LRI launches major lupus research initiative

The Lupus Research Institute (LRI) launched a major international initiative aimed at attracting the highest level scientists to conduct pioneering research to discover the fundamental root causes of lupus, explore the potential for a cure, and transform the field of lupus research.

18 Oct 2011

Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

Toronto's Globe and Mail reports on the death on Thursday of Winstone Zulu, an HIV/AIDS advocate from Zambia who lived with the virus for two decades. "His death has devastated the international community of AIDS activists," the newspaper writes.

18 Oct 2011

AHRQ: Asthma drug usage among children doubles

The proportion of children who used a prescribed controller drug to treat their asthma doubled from 29 percent in 1997-1998 to 58 percent in 2007-2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Oct 2011

Micro-electrical stimulators for spinal cord injuries

A new wireless device to help victims of spinal cord injury is receiving attention in the research community. Mesut Sahin, PhD, associate professor, in the department of biomedical engineering at NJIT, recently has published and presented news of his findings to develop micro-electrical stimulators for individuals with spinal cord injuries.

18 Oct 2011

House Foreign Affairs Committee approves bill to withhold up to half of U.S. funding to U.N.

The House Foreign Affairs Committee on Thursday approved legislation (HR 2829) that would withhold up to half of non-voluntary U.S. contributions to the United Nations "if, in two years, the United Nations is not collecting 80 percent of its regular budget in voluntary contributions," Agence France-Presse reports.

18 Oct 2011

VEGF protein appears to prevent progression of spinocerebellar ataxia type 1

A protein that promotes the growth of neurons and blood vessels appears to stop the progression of a genetic disease that causes degeneration of the cerebellum, according to new preclinical Northwestern Medicine research published in Nature Medicine.

18 Oct 2011

Give children a chance to have unstructured play

The temptation to rely on media screens to entertain babies and toddlers is more appealing than ever, with screens surrounding families at home, in the car, and even at the grocery store. And there is no shortage of media products and programming targeted to little ones. But a new policy statement from the American Academy of Pediatrics (AAP) says there are better ways to help children learn at this critical age.

18 Oct 2011

Patients with AB blood type 20% less likely to die after CABG surgery

A new study presented at ANESTHESIOLOGY 2011 focused on whether blood type affects survival after heart surgery. Researchers from Duke University Medical Center studied more than 15,000 patients to determine if a specific blood type puts patients at a higher risk for death or complications after coronary artery bypass graft (CABG) surgery.

18 Oct 2011